Loading…
Loading…
CRL · NYSE · Healthcare
“When the laboratory rats are earning more than the shareholders, perhaps it's time to question which species is running the better experiment.”
— In the voice of Munger
Side-by-side comparison of key financial metrics between two stocks to identify the better value opportunity.
Market Cap
$7.73B
P/E Ratio
-53.57
Forward P/E
—
EPS
$-2.91
PEG Ratio
-1.63
Book Value
$63.85
Dividend Yield
—
Profit Margin
-3.59%
ROE
-4.56%
Use the interactive stock comparison with pre-loaded data for Charles River Laboratories International Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for CRL: